Charles River Laboratories International, Inc. News Headlines

CRL 
$63.59
*  
0.33
0.52%
Get CRL Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading CRL now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
MedAssets Up on Contract Renewal - Analyst Blog
1/22/2014 7:30:01 PM - Zacks.com


Healthways Up on New Healthcare Deal - Analyst Blog
1/21/2014 7:20:01 PM - Zacks.com


Healthways Up on Carondelet Deal - Analyst Blog
1/17/2014 5:13:01 PM - Zacks.com


Acorda Therapeutics, Inc. (ACOR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/17/2014 7:00:01 AM - Zacks.com


MannKind Slips on Afrezza Update - Analyst Blog
1/13/2014 1:22:01 PM - Zacks.com


AstraZeneca's Farxiga Gets FDA Nod - Analyst Blog
1/9/2014 5:00:01 PM - Zacks.com


Intrexon (XON) in Focus: Stock Moves 8.4% Higher - Tale of the Tape
1/9/2014 9:46:01 AM - Zacks.com


FDA Action Date for Orexigen's Contrave - Analyst Blog
1/8/2014 5:20:01 PM - Zacks.com


MedAssets Upped to Hold - Analyst Blog
1/6/2014 6:40:01 PM - Zacks.com


Sanofi's Lemtrada Gets CRL - Analyst Blog
12/31/2013 5:49:01 PM - Zacks.com


Actavis' Women Health Biz Update - Analyst Blog
12/30/2013 2:51:01 PM - Zacks.com


MannKind Corporation (MNKD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
12/30/2013 7:00:01 AM - Zacks.com


Dynavax Submits Response to EMA - Analyst Blog
12/24/2013 12:10:01 PM - Zacks.com


Update on pSivida's Iluvien - Analyst Blog
12/19/2013 4:17:45 PM - Zacks.com


AVEO Falls on Tivozanib News - Analyst Blog
12/16/2013 6:20:01 PM - Zacks.com


Final Guidance from NICE for pSivida's Iluvien - Analyst Blog
12/5/2013 5:00:01 PM - Zacks.com


MedAssets Shares Rise on Deal Extension - Analyst Blog
12/2/2013 5:53:17 PM - Zacks.com


OREX' Positive Contrave Data Boosts Shares - Analyst Blog
11/26/2013 5:06:41 PM - Zacks.com


Regulatory Setback for Forest/Gedeon - Analyst Blog
11/22/2013 11:06:22 AM - Zacks.com


European Approval for Gilead's Vitekta - Analyst Blog
11/19/2013 11:05:54 AM - Zacks.com


Intrexon Corporation (XON) in Focus: Stock Jumps 8.6% - Tale of the Tape
11/18/2013 9:05:58 AM - Zacks.com


Narrower Q3 Loss at Progenics - Analyst Blog
11/14/2013 9:50:01 AM - Zacks.com


Narrower Loss at Orexigen in Q3 - Analyst Blog
11/14/2013 9:06:40 AM - Zacks.com


Dynavax Reports In-Line Loss, Beats Rev - Analyst Blog
11/8/2013 12:00:01 PM - Zacks.com


Salix Misses On Q3 Earnings; To Buy Santarus - Analyst Blog
11/8/2013 11:06:08 AM - Zacks.com